MIR210 as a potential molecular target to block invasion and metastasis of gastric cancer

Medical Hypotheses

Volumn 84, Issue 3, 2015, Pages 209-212

  Yu, Pengfei ^a   Fan, Sunfu ^a   Huang, Ling ^a   Yang, Litao ^a   Du, Yian ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA 210; TRANSCRIPTION FACTOR HOXA9; HIF1A PROTEIN, HUMAN; MICRORNA; MIRN210 MICRORNA, HUMAN;

ARTICLE; CANCER INHIBITION; CELL INVASION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; METASTASIS INHIBITION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; BIOLOGICAL MODEL; CELL HYPOXIA; DRUG DELIVERY SYSTEM; GENETICS; METABOLISM; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHYSIOLOGY; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

CELL HYPOXIA; DRUG DELIVERY SYSTEMS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; STOMACH NEOPLASMS;

EID: 84925351139     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.12.024     Document Type: Article

References (27)

1. Rahman R., Asombang A.W., Ibdah J.A. Characteristics of gastric cancer in Asia. World J Gastroenterol 2014, 20:4483-4490.
2. Xie X., Huang X., Li J., et al. Efficacy and safety of Huachansu combined with chemotherapy in advanced gastric cancer: a meta-analysis. Med Hypotheses 2013, 81:243-250.
3. Bauer K., Porzsolt F., Henne-Bruns D. Can perioperative chemotherapy for advanced gastric cancer be recommended on the basis of current research? A critical analysis. J Gastric Cancer 2014, 14:39-46.
4. Xia G.G., Zhang C.H., Wei Z.W., et al. Meta-analysis of adjuvant chemotherapy on prognosis for gastric cancer patients after D2 dissection. Zhonghua Wai Ke Za Zhi 2013, 51:447-451.
5. Yan L.H., Wang X.T., Yang J., et al. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation. World J Gastroenterol 2013, 19:4155-4165.
6. Tanabe S., Aoyagi K., Yokozaki H., et al. Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition. Int J Oncol 2014, 44:1955-1970.
7. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
8. Xiong L., Wang F., Huang X., et al. DNA demethylation regulates the expression of miR-210 in neural progenitor cells subjected to hypoxia. FEBS J 2012, 279:4318-4326.
9. Ivan M., Huang X. miR-210: fine-tuning the hypoxic response. Adv Exp Med Biol 2014, 772:205-227.
10. Liu F.N., Teng Y., Zhang X.X., et al. Expression of miR210 in gastric cancer and its clinical significance [in Chinese]. Chin J Clinicians. 2011, 5:2701-2703.
11. Takikawa T., Masamune A., Hamada S., et al. miR210 regulates the interaction between pancreatic cancer cells and stellate cells. Biochem Biophys Res Commun 2013, 437:433-439.
12. Du Y., Liu Z., Gu L., et al. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo. BMC Cancer 2012, 12:249.
13. Yoo Y.A., Kang M.H., Lee H.J., et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 2011, 71:7061-7070.
14. Xu Z.Y., Yu Q.M., Du Y.A., et al. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci 2013, 9:587-597.
15. Xu C.H., Guo H.M., Wang J., et al. Reversion of resistance of human gastric cancer cell line SGC7901/DDP to cisplatin by a miRNA-snail and its possible mechanism [in Chinese]. Chin J Gastroenterol 2012, 3:146-150.
16. Semenza G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29:625-634.
17. Zhou J., Li K., Gu Y., et al. Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia. Biochem Biophys Res Commun 2011, 415:348-354.
18. Jiang J., Tang Y.L., Liang X.H. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther 2011, 11:714-723.
19. Matsuoka J., Yashiro M., Doi Y., et al. Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling. PLoS One 2013, 8(5). e62310.
20. Devlin C., Greco S., Martelli F., et al. MiR-210: more than a silent player in hypoxia. IUBMB Life 2011, 63:94-100.
21. Toyama T., Kondo N., Endo Y., et al. High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol 2012, 42:256-263.
22. Ying Q., Liang L., Guo W., et al. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 2011, 54:2064-2075.
23. Rotkrua P., Shimada S., Mogushi K., et al. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model. Br J Cancer 2013, 108:932-940.
24. Huang X., Ding L., Bennewith K.L., et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 2009, 35:856-867.
25. Halle M., Gabrielsen A., Paulsson-Berne G., et al. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol 2010, 55:1227-1236.
26. Yang Y.C., Wang S.W., Wu I.C., et al. A tumorigenic homeobox (HOX) gene expressing human gastric cell line derived from putative gastric stem cell. Eur J Gastroenterol Hepatol 2009, 21:1016-1023.
27. Zhang Y., Fei M., Xue G., et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med 2012, 16:249-259.